Trial Profile
An observational study in Japanese patients to evaluate the disease activity in patients with rheumatoid arthritis after switching from tumour necrosis factor inhibitors to abatacept
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Feb 2016
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 11 Feb 2016 New trial record